BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30787420)

  • 1. A novel benzamine lead compound of histone deacetylase inhibitor ZINC24469384 can suppresses HepG2 cells proliferation by upregulating NR1H4.
    Song Q; Li M; Fan C; Liu Y; Zheng L; Bao Y; Sun L; Yu C; Song Z; Sun Y; Wang G; Huang Y; Li Y
    Sci Rep; 2019 Feb; 9(1):2350. PubMed ID: 30787420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitor quisinostat activates caspase signaling and upregulates p53 acetylation to inhibit the proliferation of HepG2 cells.
    Li F; Wang T; Wang Z; Chen X; Liu R
    Mol Med Rep; 2017 Nov; 16(5):6094-6101. PubMed ID: 28849080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Improved Protocol for the Virtual Screening Discovery of Novel Histone Deacetylase Inhibitors.
    Song Q; Liu T; Liu Y; Wang S; Fan C; Zheng L; Bao Y; Sun L; Yu C; Sun Y; Song Z; Wang G; Huang Y; Li Y
    Chem Pharm Bull (Tokyo); 2019 Oct; 67(10):1076-1081. PubMed ID: 31406093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
    Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
    Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitor BML-210 induces growth inhibition and apoptosis and regulates HDAC and DAPC complex expression levels in cervical cancer cells.
    Borutinskaite VV; Magnusson KE; Navakauskiene R
    Mol Biol Rep; 2012 Dec; 39(12):10179-86. PubMed ID: 23007576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of trichostatin A on anti HepG2 liver carcinoma cells: inhibition of HDAC activity and activation of Wnt/β-Catenin signaling.
    Shi QQ; Zuo GW; Feng ZQ; Zhao LC; Luo L; You ZM; Li DY; Xia J; Li J; Chen DL
    Asian Pac J Cancer Prev; 2014; 15(18):7849-55. PubMed ID: 25292076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosmarinic Acid, a Component of Rosemary Tea, Induced the Cell Cycle Arrest and Apoptosis through Modulation of HDAC2 Expression in Prostate Cancer Cell Lines.
    Jang YG; Hwang KA; Choi KC
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brazilin induces apoptosis and G2/M arrest via inactivation of histone deacetylase in multiple myeloma U266 cells.
    Kim B; Kim SH; Jeong SJ; Sohn EJ; Jung JH; Lee MH; Kim SH
    J Agric Food Chem; 2012 Oct; 60(39):9882-9. PubMed ID: 22967175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenoside 20(s)-Rh2 as potent natural histone deacetylase inhibitors suppressing the growth of human leukemia cells.
    Liu ZH; Li J; Xia J; Jiang R; Zuo GW; Li XP; Chen Y; Xiong W; Chen DL
    Chem Biol Interact; 2015 Dec; 242():227-34. PubMed ID: 26482938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aurora-B and HDAC synergistically regulate survival and proliferation of lymphoma cell via AKT, mTOR and Notch pathways.
    Wang C; Chen J; Cao W; Sun L; Sun H; Liu Y
    Eur J Pharmacol; 2016 May; 779():1-7. PubMed ID: 26638998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aza-PBHA, a potent histone deacetylase inhibitor, inhibits human gastric-cancer cell migration via PKCα-mediated AHR-HDAC interactions.
    Tsai CH; Li CH; Liao PL; Chang YW; Cheng YW; Kang JJ
    Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118564. PubMed ID: 31672612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compound K, a metabolite of ginseng saponin, inhibits colorectal cancer cell growth and induces apoptosis through inhibition of histone deacetylase activity.
    Kang KA; Piao MJ; Kim KC; Zheng J; Yao CW; Cha JW; Kim HS; Kim DH; Bae SC; Hyun JW
    Int J Oncol; 2013 Dec; 43(6):1907-14. PubMed ID: 24100442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways.
    Hrgovic I; Doll M; Kleemann J; Wang XF; Zoeller N; Pinter A; Kippenberger S; Kaufmann R; Meissner M
    BMC Cancer; 2016 Sep; 16(1):763. PubMed ID: 27716272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of p21(waf1/cip1) and p27(Kip1) in HDACi-mediated tumor cell death and cell cycle arrest in the Eμ-myc model of B-cell lymphoma.
    Newbold A; Salmon JM; Martin BP; Stanley K; Johnstone RW
    Oncogene; 2014 Nov; 33(47):5415-23. PubMed ID: 24292681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
    Niegisch G; Knievel J; Koch A; Hader C; Fischer U; Albers P; Schulz WA
    Urol Oncol; 2013 Nov; 31(8):1770-9. PubMed ID: 22944197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class I histone deacetylases regulate p53/NF-κB crosstalk in cancer cells.
    Schäfer C; Göder A; Beyer M; Kiweler N; Mahendrarajah N; Rauch A; Nikolova T; Stojanovic N; Wieczorek M; Reich TR; Tomicic MT; Linnebacher M; Sonnemann J; Dietrich S; Sellmer A; Mahboobi S; Heinzel T; Schneider G; Krämer OH
    Cell Signal; 2017 Jan; 29():218-225. PubMed ID: 27838375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel Flavone-based histone deacetylase inhibitors antagonizing activation of STAT3 in breast cancer.
    Wei M; Xie M; Zhang Z; Wei Y; Zhang J; Pan H; Li B; Wang J; Song Y; Chong C; Zhao R; Wang J; Yu L; Yang G; Yang C
    Eur J Med Chem; 2020 Nov; 206():112677. PubMed ID: 32823005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effects of a novel histone deacetylase inhibitor NK-HDAC-1 on breast cancer.
    Li ZH; Zhang XB; Han XQ; Feng CR; Wang FS; Wang PG; Shen J; Shi YK
    Oncol Rep; 2013 Jul; 30(1):499-505. PubMed ID: 23624828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel class I histone deacetylase inhibitor, I-7ab, induces apoptosis and arrests cell cycle progression in human colorectal cancer cells.
    Yang L; Liang Q; Shen K; Ma L; An N; Deng W; Fei Z; Liu J
    Biomed Pharmacother; 2015 Apr; 71():70-8. PubMed ID: 25960218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, characterization, and evaluation of Cd[L-proline]
    Chidambaram A; Sekar A; S H K; Chidambaram RK; Arunachalam K; G P S; Vilwanathan R
    Invest New Drugs; 2017 Dec; 35(6):691-705. PubMed ID: 28776290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.